Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 23, 2024
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
Mathew Blackman Maintained (TNDM) at Strong Buy with Increased Target to $40 on, Apr 23rd, 2024
Mathew Blackman of Stifel, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Increased Target from $37 to $40 on, Apr 23rd, 2024.
Mathew has made no other calls on TNDM in the last 4 months.
There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, all agree with Mathew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $38 on, Wednesday, April 3rd, 2024
- Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024
